Northwestern University
Open enrollment with an early-phase pipeline tilt
According to ClinicalTrials.gov-derived indexes, Northwestern University sits in the top decile of US sponsors by registered trial count (#23 of 15,742 sponsors by registered trial count).
Northwestern University: 1,209 sponsored US clinical trials, 187 recruiting.
Northwestern University sponsors 1,209 registered US clinical trials on ClinicalTrials.gov, 187 of them currently recruiting, and 767 completed. 114 of these trials are in Phase 3-4 (later-stage) and 295 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Depression, with 11 trials.
Top-decile sponsor footprint
Northwestern University ranks in the top decile of sponsors by registered trial count (#23 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Trial completion reliability score
767 of 912 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (84.1%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.
Open and recent trials
1,209 total, page 12 of 25
Denosumab in Treating Patients With ER and/or PR Positive, HER2 Negative Metastatic Breast Cancer With Bone Metastases and Detectable Circulating Tumor Cells
NCT03070002
Nilotinib in Parkinson's Disease
NCT03205488
Dupilumab Phase 4 Study
NCT03411837
US Guided GNB vs Saline Injection for TKA
NCT03316118
The Smart Hypertension Control Study
NCT03288142
Ipilimumab and Nivolumab in Treating Patients With Recurrent Stage IV HER2 Negative Inflammatory Breast Cancer
NCT02892734
Early Amniotomy Versus Delayed Amniotomy Following Foley Catheter Ripening in Nulliparous Labor Induction
NCT03039036
Gene Expression and Biomarker Profiling of Keloid Skin
NCT03228693
Prostatic Artery Embolization (PAE) for Treatment of Signs and Symptoms of Benign Prostatic Hyperplasia (BPH) Using Bead Block Microspheres
NCT03052049
Morning Light Treatment to Improve Glucose Metabolism
NCT03188263
Randomized Trial of an HIV Prevention and Relationship Education Program for Young Male Couples
NCT03186534
Nivolumab and Dasatinib in Treating Patients With Relapsed or Refractory Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia
NCT02819804
Perceptual Expertise Training for Triage of Moles
NCT03246633
SweetMama: Testing of a Novel Technology for Diabetes Education and Support to Pregnant Women
NCT03240874
Histology Post-Endoscopic Eradication Therapy (EET)
NCT03375060
Tolerance of Chlorhexidine Gluconate Vaginal Cleansing Solution
NCT03305159
Mast Cells in Male Pelvic Pain and and Lower Urinary Tract Dysfunction
NCT03167216
Feasibility of a Technology-Based Treatment Support System
NCT03121937
Biomarker Analyses in Hepatocellular Carcinoma (HCC) Patients Treated With TheraSphere®
NCT03203837
Effectiveness of Physiologic Testing in PPI Non-Responders
NCT03202537
Assessment of Dermatologists at Skin of Color Clinics
NCT03201029
Hats on Head Start: A A Survey of Sun Protection Behaviors in Head Start and Other Early Childhood Education Programs
NCT03199573
Creating and Optimizing Mindfulness Measures to Enhance and Normalize Clinical Evaluation
NCT03510117
Sense2Stop:Mobile Sensor Data to Knowledge
NCT03184389
SMART Weight Loss Management
NCT02997943
Introduction and Maintenance of Still Eating Protein Blends in Support of Infant Nutritional Goals
NCT03667118
Masculine Norms and Skin Care Knowledge, Attitudes, and Behaviors
NCT03191747
Testing a Medication Risk Communication and Surveillance Strategy: The EMC2 Trial
NCT02785458
Integrating Text Messages Into the Mothers and Babies Course
NCT03420755
Efficacy of Gadoterate Meglumine in Diagnosis of Vascular Diseases Using MRA MRA
NCT05199792
Postpartum Opioid Prescribing Patterns and Patient Utilization
NCT03030742
Use of Simulation to Improve VAD Self-management
NCT03073005
Effects of Stellate Ganglion Block on Hot Flashes in Hispanic Women With Breast Cancer
NCT03122301
Testing an Active Form of Tamoxifen (4-hydroxytamoxifen) Delivered Through Breast Skin to Control Ductal Carcinoma in Situ (DCIS) of the Breast
NCT02993159
NU-0129 in Treating Patients With Recurrent Glioblastoma or Gliosarcoma Undergoing Surgery
NCT03020017
Phase I/Ib Study of Nivolumab & Veliparib in Patients With Advanced Solid Tumors & Lymphoma
NCT03061188
Mild Cognitive Impairment and Endurance Exercise in Parkinson's Disease
NCT03542474
Optimization of Remotely Delivered Physical Activity Intervention for Breast Cancer Survivors
NCT03131440
Neural Stem Cell Based Virotherapy of Newly Diagnosed Malignant Glioma
NCT03072134
Reducing Tobacco Use Disparities Among Low-Income Adults
NCT03077737
The Effects of Capsinoids on Brown Adipose Tissue Activation in Obesity
NCT03110809
Perioperative Active Warming Techniques in Colorectal Surgeries
NCT00913978
Topical Sildenafil as Pre-Treatment for Hand-Foot Skin Reaction
NCT03229512
A Universal Medication Schedule to Promote Adherence to Complex Drug Regimens
NCT02820753
Implementing Resistance Exercise to Reduce Frailty for Older Adult
NCT02942992
LiveWell: A Mobile Intervention for Bipolar Disorder
NCT03088462
Yttrium-90 Radioembolization for Cirrhosis-Associated Thrombocytopenia
NCT03059030
Promoting Early Detection of Melanoma During the Mammography Experience
NCT03057327
A Study of Topical Steroids as Preemptive Therapy for EGFR Inhibitor-Induced Papulopustular Eruption
NCT03115567
Pembrolizumab and BCG Solution in Treating Patients With Recurrent Non-Muscle-Invasive Bladder Cancer
NCT02808143
What is open in the Northwestern University pipeline
187 recruiting of 1,209 indexed (15% open); 767 completed (63%).
Phase mix: 114 late (III/IV) vs 295 early (I/II) (early-phase heavy).
Top condition: Depression (11 trials), 9 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
Northwestern University: open-pipeline peers nationwide
Peers matched on 1,209 registered trials and 15% open enrollment, not the therapeutic-area sidebar.
Northwestern University sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 1,209 trials (± recruiting share)
- Emory University · 1,208 trials · 17% recruiting
- University of Pittsburgh · 1,238 trials · 13% recruiting
- NYU Langone Health · 1,164 trials · 17% recruiting
- University of Alabama at Birmingham · 1,160 trials · 19% recruiting
Sponsors near 15% open enrollment (± trial volume)
- Brigham and Women's Hospital · 15% recruiting · 937 trials
- Incyte Corporation · 15% recruiting · 239 trials
- Nationwide Children's Hospital · 15% recruiting · 188 trials
- University of Michigan Rogel Cancer Center · 15% recruiting · 292 trials
Related
What to do with this Northwestern University page
1,209 registered trials is a research-attention snapshot, not an endorsement of Northwestern University or any single study.
- 187 of Northwestern University's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Depression is the condition Northwestern University studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Depression trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. Northwestern University pipeline card: 1,209 registered trials from official public datasets. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.